Physician

Robert L Steinmetz, M.D.

According to 2025 Medicare claims, Robert Steinmetz, M.D. (NPI: 1194782508) practices ophthalmology in the Tallahassee, FL market, with the plurality of this provider's patient population coming from Leon, FL. This provider's primary affiliated billing organization is SOUTHERN VITREORETINAL ASSOCIATES, PL (NPI: 1871665448; TIN: 208515285) and primary practice location at 31707-0209.

Steinmetz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 609 traditional Medicare patients, billed 61,243 HCPCS/CPT codes, and received $2,583,814 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 373 prescription claims across 154 beneficiaries totaling $12,875 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 21 records totaling $46,039. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $4,053,187 to $2,583,814. Similarly, Part D prescription costs have declined steadily, from $24,140 to $12,875. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.2M$4.4M2015 Medicare payment: $4,053,187 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,199,766 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,266,620 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,411,191 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,112,609 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,443,988 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,985,546 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,786,814 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,432,854 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,583,814 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201588819,593$4,053,187
20161,00819,993$4,199,766
201796219,870$4,266,620
201895920,424$4,411,191
201986018,828$4,112,609
202075416,160$3,443,988
202169513,856$2,985,546
202270514,991$2,786,814
202364331,796$2,432,854
202460961,243$2,583,814

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$13K$26K2015 Drug cost: $24,140 (USD; Tot_Drug_Cst)2016 Drug cost: $20,272 (USD; Tot_Drug_Cst)2017 Drug cost: $26,186 (USD; Tot_Drug_Cst)2018 Drug cost: $22,737 (USD; Tot_Drug_Cst)2019 Drug cost: $21,371 (USD; Tot_Drug_Cst)2020 Drug cost: $16,440 (USD; Tot_Drug_Cst)2021 Drug cost: $14,529 (USD; Tot_Drug_Cst)2022 Drug cost: $15,548 (USD; Tot_Drug_Cst)2023 Drug cost: $14,442 (USD; Tot_Drug_Cst)2024 Drug cost: $12,875 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015155519$24,140
2016152525$20,272
2017178671$26,186
2018157520$22,737
2019147332$21,371
2020107273$16,440
2021138300$14,529
2022133316$15,548
2023121267$14,442
2024154373$12,875

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3211,636$87
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more204262$62
92134Imaging of retina4711,729$29
J2777Injection, faricimab-svoa, 0.1 mg17052,680$27
92250Photography of the retina192265$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1805,779$8,608
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim1394,957$1,081

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$334Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.9$45,705Kyowa Kirin, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.1$280,063US Retina LLC

FAQ

What Medicare data is available for Robert L. Steinmetz, M.D.?

Tedicare shows public-source Medicare data for Robert L. Steinmetz, M.D. (NPI 1194782508), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert L. Steinmetz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert L. Steinmetz, M.D.?

Robert L. Steinmetz, M.D. is linked to SOUTHERN VITREORETINAL ASSOCIATES, PL (billing NPI 1871665448) in the available physician profile data.

Does Robert L. Steinmetz, M.D. have Open Payments data?

Robert L. Steinmetz, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.